TYK2 and cancer: Meanwhile, suppression Tyk2 cascade was shown to interrupt such oncogenic signaling cascades, which could potentially contribute to its anti-tumor effects in preclinical cancer models (Caldas-Lopes et al., 2009; Kucine et al., 2015).